Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1-2 Clinical Trial.

Lemos-Pérez G, Barrese-Pérez Y, Chacón-Quintero Y, Uranga-Piña R, Avila-Albuerne Y, Figueroa-García I, Calderín-Marín O, Gómez-Vázquez MM, Piñera-Martínez M, Chávez-Valdés S, Martínez-Rosales R, Ávila-Díaz L, Vázquez-Arteaga A, González-Formental H, Freyre-Corrales G, Coizeau-Rodríguez E, Limonta-Fernández M, Ayala-Avila M, Martínez-Díaz E, Pimentel-Vazquez E, Guillen G.

Open source

DOI: 10.3390/vaccines12091001
Published: 2024-09-01
Container: Vaccines (Basel)
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/vaccines12091001,
  title = {Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1-2 Clinical Trial.},
  author = {Lemos-Pérez G and  Barrese-Pérez Y and  Chacón-Quintero Y and  Uranga-Piña R and  Avila-Albuerne Y and  Figueroa-García I and  Calderín-Marín O and  Gómez-Vázquez MM and  Piñera-Martínez M and  Chávez-Valdés S and  Martínez-Rosales R and  Ávila-Díaz L and  Vázquez-Arteaga A and  González-Formental H and  Freyre-Corrales G and  Coizeau-Rodríguez E and  Limonta-Fernández M and  Ayala-Avila M and  Martínez-Díaz E and  Pimentel-Vazquez E and  Guillen G.},
  year = {2024},
  journal = {Vaccines (Basel)},
  doi = {10.3390/vaccines12091001},
  url = {https://doi.org/10.3390/vaccines12091001}
}

RIS

TY  - JOUR
TI  - Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1-2 Clinical Trial.
AU  - Lemos-Pérez G
AU  -  Barrese-Pérez Y
AU  -  Chacón-Quintero Y
AU  -  Uranga-Piña R
AU  -  Avila-Albuerne Y
AU  -  Figueroa-García I
AU  -  Calderín-Marín O
AU  -  Gómez-Vázquez MM
AU  -  Piñera-Martínez M
AU  -  Chávez-Valdés S
AU  -  Martínez-Rosales R
AU  -  Ávila-Díaz L
AU  -  Vázquez-Arteaga A
AU  -  González-Formental H
AU  -  Freyre-Corrales G
AU  -  Coizeau-Rodríguez E
AU  -  Limonta-Fernández M
AU  -  Ayala-Avila M
AU  -  Martínez-Díaz E
AU  -  Pimentel-Vazquez E
AU  -  Guillen G.
PY  - 2024
JO  - Vaccines (Basel)
DO  - 10.3390/vaccines12091001
UR  - https://doi.org/10.3390/vaccines12091001
ER  -

APA

G, L., Y, B., Y, C., R, U., Y, A., I, F., O, C., MM, G., M, P., S, C., R, M., L, Á., A, V., H, G., G, F., E, C., M, L., M, A., E, M., E, P., & G., G. (2024). Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1-2 Clinical Trial.. Vaccines (Basel). https://doi.org/10.3390/vaccines12091001

Source records

europe-pmc · retrieved 2026-09-27T15:19:57.249Z
doaj · retrieved 2026-09-27T15:19:57.214Z